BASEL, Switzerland, Sept. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution ...
Roche Holding RHHBY recently announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. With the approval, CGM solution can now be made ...
Roche RHHBY is set to enter the competitive continuous glucose monitor (CGM) market in Europe following the CE mark approval of its Accu-Chek Smartguide in July. The Swiss pharmaceutical company plans ...
First diabetes data management platform outside of Roche’s ecosystem to integrate with Accu-Chek SmartGuide CGM, bringing more choice and a more complete view of data to people with diabetes and their ...
The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease. Accu-Chek ...
During the symposium Roche shared real-world data from Accu-Chek SmartGuide Predict app users on the clinical effect of Night Low Predict use. In this analysis, using Night Low Predict was linked to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results